This podcast episode delves into the dynamic world of small-cap investing, emphasizing its unique potential for growth and value creation often overlooked by institutional investors. Bill Mann articulates that identifying the right management quality is crucial, with particular attention to the CEO's capabilities. The discussion highlights varying investment approaches—including speculative 'bottle rocket' companies, quality low-key firms, and turnaround stories—while providing concrete examples like Walgreens and CRISPR Therapeutics. Ultimately, the episode advocates for the merits of small-cap investments, encouraging patience and careful selection to unlock substantial returns.
